ACCORD BIOPHARMA INC recalls IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL
See all recalls from ACCORD BIOPHARMA INC →Recalled Product
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.
Hazard / Issue
Lack of assurance of Sterility:
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot # 004L24A, Exp Date: 02/19/2027.
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for IMULDOSA, (ustekinumab-srlf) Injection, 130 →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime